Dr. Reddy’s Laboratories has informed NSE that the wholly-owned subsidiary of the Company, namely, Dr. Reddy’s Laboratories SA, Switzerland has entered into a definitive agreement with Haleon plc and its associate companies (“Haleon Group”) to acquire Nicotinell® and related brands by way of acquisition of all of the quotas of Northstar Switzerland SARL (“Northstar Switzerland”) incorporated in Switzerland having registration no. CHE-221.039.836 owned by the Haleon Group with step-down subsidiaries in the United Kingdom and Sweden. Consequently, the said companies will be step-down wholly owned subsidiaries of the Company.
Dr. Reddy’s Laboratories Limited has informed the Exchange about Acquisition
